This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Etoposide
  • /
  • A Randomized, Open-label, Safety and Efficacy Stud...
Clinical trial

A Randomized, Open-label, Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Patients With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma

Read time: 2 mins
Last updated:1st Jul 2016
Identifier: NCT02703272
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest